DrugPatentWatch Database Preview

Details for Patent: 8,920,392

« Back to Dashboard

Which drugs does patent 8,920,392 protect, and when does it expire?

Patent 8,920,392 protects GELNIQUE and is included in one NDA.

This patent has eighteen patent family members in thirteen countries.

Summary for Patent: 8,920,392

Title:	Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
Abstract:	The invention relates to a method for treating overactive bladders and a device for storing and administering non-occluded oxybutynin topical compositions.
Inventor(s):	Gochnour; Scott (Salt Lake City, UT), Subramanyan; Venkatesh (Salt Lake City, UT), Kimball; Michael W. (Salt Lake City, UT)
Assignee:	Watson Laboratories, Inc. (Salt Lake City, UT)
Application Number:	12/435,895
Patent Claim Types: see list of patent claims	Composition; Compound; Device; Formulation; Use;

Drugs Protected by US Patent 8,920,392

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Allergan Sales Llc	GELNIQUE	oxybutynin chloride	GEL;TRANSDERMAL	022204-001	Jan 27, 2009		RX	Yes	Yes						TREATMENT OF OVERACTIVE BLADDER BY APPLICATION OF OXYBUTYNIN CHLORIDE GEL TO SKIN

Non-Orange Book US Patents Family Members for Patent 8,920,392

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
9,259,388	Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions

International Family Members for US Patent 8,920,392

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2010246103
Brazil	PI1015542
Canada	2760867
Canada	2821174